Orthofix Medical (NASDAQ:OFIX) reported its Q1 earnings results on Friday, May 6, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Orthofix Medical missed estimated earnings by 211.11%, reporting an EPS of $-0.1 versus an estimate of $0.09.
Revenue was up $825.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.14 which was followed by a 1.32% increase in the share price the next day.
Here's a look at Orthofix Medical's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.13 | 0.11 | 0.11 | 0.02 |
| EPS Actual | 0.27 | 0.10 | 0.32 | 0.17 |
| Revenue Estimate | 124.87M | 113.31M | 108.20M | 95.61M |
| Revenue Actual | 125.06M | 112.43M | 121.39M | 105.59M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
Orthofix Medical management provided guidance for FY 2022, expecting earnings between $0.58 and $0.73 per share.
To track all earnings releases for Orthofix Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
